Skip to NavigationSkip to content


Third quarter sales down by $600 million
Company chases GSK in diabetes type II market
Drug abandoned after trials fail to show benefits
New US complex will be company's "crown jewel"
Early access to Shire's drug granted to treat patients in Europe
PCTs come out worst in performance review
Acquisition fills major gap in company's portfolio
Pfizer and Eisai considering legal challenge
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches